Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 780,463,104
  • Shares Outstanding, K 950,405
  • Annual Sales, $ 34,124 M
  • Annual Income, $ 5,240 M
  • 60-Month Beta 0.41
  • Price/Sales 23.95
  • Price/Cash Flow 115.16
  • Price/Book 64.72
Trade LLY with:

Options Overview Details

View History
  • Implied Volatility 38.68% ( -1.52%)
  • Historical Volatility 30.51%
  • IV Percentile 99%
  • IV Rank 92.82%
  • IV High 40.20% on 07/25/24
  • IV Low 19.01% on 09/01/23
  • Put/Call Vol Ratio 0.95
  • Today's Volume 42,198
  • Volume Avg (30-Day) 47,321
  • Put/Call OI Ratio 0.89
  • Today's Open Interest 306,011
  • Open Int (30-Day) 285,949

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 2.66
  • Number of Estimates 9
  • High Estimate 2.95
  • Low Estimate 2.22
  • Prior Year 2.11
  • Growth Rate Est. (year over year) +26.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
801.30 +0.41%
on 07/26/24
966.10 -16.71%
on 07/15/24
-96.64 (-10.72%)
since 06/26/24
3-Month
729.61 +10.28%
on 04/29/24
966.10 -16.71%
on 07/15/24
+71.11 (+9.69%)
since 04/26/24
52-Week
446.89 +80.05%
on 08/04/23
966.10 -16.71%
on 07/15/24
+351.03 (+77.39%)
since 07/26/23

Most Recent Stories

More News
Prediction: This Is What Eli Lilly Stock Will Do Next

Shares of Eli Lilly are up more than 130% in the past year, but this company's moves are far from finished.

COMP : 4.44 (+2.78%)
LLY : 804.62 (-2.02%)
Why Weight Loss Drug Developer Stocks Tumbled on Thursday

Companies like Novo Nordisk and Eli Lilly might soon have a determined competitor in their hottest product category.

VKTX : 65.98 (+2.01%)
RHHBY : 40.7600 (+3.03%)
NVO : 126.73 (-0.88%)
LLY : 804.62 (-2.02%)
Why Viking Therapeutics Stock Is Skyrocketing Today

The clinical-stage biopharmaceutical company should soon be closer to potentially launching its first product.

LLY : 804.62 (-2.02%)
VKTX : 65.98 (+2.01%)
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected

EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NASDAQ:AXSM) EQNX::TICKER_END

TNXP : 0.5500 (-5.09%)
LLY : 804.62 (-2.02%)
PFE : 30.77 (+3.39%)
ABBV : 185.16 (+1.64%)
AXSM : 86.53 (+0.64%)
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected

TNXP : 0.5500 (-5.09%)
LLY : 804.62 (-2.02%)
PFE : 30.77 (+3.39%)
ABBV : 185.16 (+1.64%)
AXSM : 86.53 (+0.64%)
ResMed Earnings Preview: What to Expect

ResMed will release its fourth-quarter earnings next month, and analysts anticipate a double-digit profit growth.

RMD : 197.04 (-5.42%)
$SPX : 5,459.10 (+1.11%)
XLV : 149.96 (+0.56%)
LLY : 804.62 (-2.02%)
3 Dividend Growth Stocks That Have Doubled Their Payouts in 5 Years

Their yields may seem low, but these stocks have been growing their dividend payments at a fast pace.

LLY : 804.62 (-2.02%)
AVGO : 151.63 (+1.59%)
MA : 438.18 (+2.00%)
If You'd Invested $10,000 in Eli Lilly Stock 5 Years Ago, Here's How Much You'd Have Today

Could today's momentum continue?

LLY : 804.62 (-2.02%)
What You Need to Know Ahead of Eli Lilly's Earnings Release

As Eli Lilly gears up to release its second-quarter earnings next month, analysts project a double-digit bottom-line growth.

LLY : 804.62 (-2.02%)
$SPX : 5,459.10 (+1.11%)
XLV : 149.96 (+0.56%)
MORF : 56.55 (-0.11%)
Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?

Roche might give Lilly and Novo Nordisk a run for their money -- sometime down the road.

NVO : 126.73 (-0.88%)
LLY : 804.62 (-2.02%)
RHHBY : 40.7600 (+3.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Eli Lilly and Company, one of the world's largest pharmaceutical companies, boasts a diversified product profile including a solid lineup of new successful drugs. It also has a dependable pipeline as it navigates through challenges like patent expirations of several drugs and rising pricing pressure...

See More

Key Turning Points

3rd Resistance Point 838.03
2nd Resistance Point 830.02
1st Resistance Point 817.32
Last Price 804.62
1st Support Level 796.61
2nd Support Level 788.60
3rd Support Level 775.90

See More

52-Week High 966.10
Last Price 804.62
Fibonacci 61.8% 767.76
Fibonacci 50% 706.49
Fibonacci 38.2% 645.23
52-Week Low 446.89

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar